Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report.
Saved in:
| Title: | Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report. |
|---|---|
| Authors: | Yasu T; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan., Ohta H; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan., Gando Y; Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan., Kobayashi M; Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo 130-8575, Japan.; Department of Hematology, Tokyo Metropolitan Bokutoh Hospital, Tokyo 130-8575, Japan. |
| Source: | Oncology letters [Oncol Lett] 2026 Mar 17; Vol. 31 (5), pp. 176. Date of Electronic Publication: 2026 Mar 17 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1792-1082 |
|---|---|
| DOI: | 10.3892/ol.2026.15531 |